Maltoni, R.; Balzi, W.; Rossi, T.; Fabbri, F.; Bravaccini, S.; Montella, M.T.; Massa, I.; Bertoni, L.; Falcini, F.; Altini, M.
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. Curr. Oncol. 2022, 29, 433-438.
https://doi.org/10.3390/curroncol29020039
AMA Style
Maltoni R, Balzi W, Rossi T, Fabbri F, Bravaccini S, Montella MT, Massa I, Bertoni L, Falcini F, Altini M.
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. Current Oncology. 2022; 29(2):433-438.
https://doi.org/10.3390/curroncol29020039
Chicago/Turabian Style
Maltoni, Roberta, William Balzi, Tania Rossi, Francesco Fabbri, Sara Bravaccini, Maria Teresa Montella, Ilaria Massa, Lucia Bertoni, Fabio Falcini, and Mattia Altini.
2022. "Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study" Current Oncology 29, no. 2: 433-438.
https://doi.org/10.3390/curroncol29020039
APA Style
Maltoni, R., Balzi, W., Rossi, T., Fabbri, F., Bravaccini, S., Montella, M. T., Massa, I., Bertoni, L., Falcini, F., & Altini, M.
(2022). Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. Current Oncology, 29(2), 433-438.
https://doi.org/10.3390/curroncol29020039